VistaGen Therapeutics Inc (NASDAQ:VTGN)
| 0.155 Delayed Data As of Aug 05 |  +0.003 / +1.97%Today’s Change | 0.14 Today|||52-Week Range 3.26 | -92.05% Year-to-Date |
Latest VTGN News | Press Releases
No recent news for VistaGen Therapeutics Inc.
Today’s Trading
| Previous close | 0.15 |
| Today’s open | 0.15 |
| Day’s range | 0.15 - 0.16 |
| Volume | 19,358,697 |
| Average volume (3 months) | 6,115,591 |
| Market cap | $32.0M |
Data as of 4:01pm ET, 08/05/2022
Growth & Valuation
| Earnings growth (last year) | +49.93% |
| Earnings growth (this year) | +6.00% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +1.78% |
| P/E ratio | NM |
| Price/Sales | 221.39 |
| Price/Book | 0.49 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CLBSCaladrius Bioscience... | -0.01 | -1.94% |
| APLTApplied Therapeutics... | +0.10 | +8.26% |
| BPTHBio Path Holdings In... | +0.16 | +4.11% |
| IGCIndia Globalization ... | +0.01 | +1.84% |
Data as of 4:03pm ET, 08/05/2022
Financials
| Next reporting date | August 16, 2022 |
| EPS forecast (this quarter) | -$0.08 |
| Annual revenue (last year) | $1.1M |
| Annual profit (last year) | -$47.8M |
| Net profit margin | -4,307.19% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
